 Julie C. Harper
Julie C. Harper, MD, is a Clinical Associate Professor of Dermatology at the University of Alabama-Birmingham.
She received her medical degree from the University of Missouri, Columbia School of Medicine, and went on to complete an internship in Internal Medicine. She completed her dermatology residency at the University of Missouri, Columbia and her undergraduate degree at Southeast Missouri State University.
Dr. Harper is founding director of the American Acne and Rosacea Society, a task force member of American Academy of Dermatology Telemedicine, a former American Academy of Dermatology Leadership Retreat Participant, and a former Women's Dermatologic Society Board of Directors Young Physician Representative.
She has written and spoken on the subject of acne and rosacea extensively. Some of Dr. Harper's writings can be found in journals such as Practical Dermatology Advances in Dermatology, and Cecil's Review of General Internal Medicine 8th edition.
Education:
- 1987-1991
Southeast Missouri State University
B.S.
- 1992-1996
University of Missouri-Columbia School of Medicine
M.D.
- 1996-1997
University of Missouri-Columbia
Internal Medicine Internship
- 1997-2000
University of Missouri-Columbia
Dermatology Residency
Academic Appointments:
- 2007 – Present
The Dermatology and Skin Care Center of Birmingham- Private Practice
- 2007 – Present
University of Alabama-Birmingham
Department of Dermatology
Clinical Associate Professor
- 2005-2006
University of Alabama-Birmingham
Department of Dermatology
Associate Professor
Residency Program Director
- 2000-2005
University of Alabama-Birmingham
Department of Dermatology
Assistant Professor
Assistant Residency Program Director
Certification:
- American Board of Dermatology
October 2000
Licensure:
Honors/Awards:
1996 Alpha Omega Alpha honor Society
1995-96 Senior Medical School Class Vice-President
1996 Dermatology Clerkship Award
1991 Beta Beta Beta Biology Honor Society
1988 Phi Eta Sigma Freshman Honor Society
Activities Committees:
2010-present AAD Private Sector Advocacy Task Force
2009-2010 President of the Alabama Dermatological Society
2008-2009 President elect of the Alabama Dermatological Society
2007-2008 Treasurer/Secretary of the Alabama Dermatological Society
2005-present American Acne and Rosacea Society
Founding Director
2006 Faculty of 1000
Faculty contributor
2004 Practical Dermatology
Contributing Editor
2003-2005 American Academy of Dermatology
Telemedicine Task Force
2003-2007 Dean’s Council of Graduate Medical Education
2002-2005 American Academy of Dermatology
Allied Health Professionals Task Force
2002 American Academy of Dermatology Leadership Retreat
Participant
2002-2005 UAB Medical Education Committee
2002-2005 Women’s Dermatologic Society
Chair-website committee
2001-2002 Medical Education Assessment Committee
2001-2006 UAB medical student mentor
2001 Women’s Dermatologic Society Board of Directors
Young Physician Representative
2000-2001 American Academy of Dermatology
Telemedicine Task Force
1999 Camp Discovery
Counselor
Publications/Posters:
Harper JC. Benzoyl peroxide development, pharmacology, formulation and clinical uses in topical fixed combinations. J Drugs Dermatol. 2010 May;9(5):482-7.
Harper JC. Should dermatologists prescribe hormonal contraceptives for acne? Dermatol Ther. 2009 Sep-Oct;22(5):452-7.
Harper JC. Evaluating hyperandrogenism: a challenge in acne management. J Drugs Dermatol. 2008 Jun;7(6):527-30.
Thiboutot DM, Harper JC, O'Connell K, Rich P, Sondheimer SJ. Improving outcomes through collaboration. Cutis. 2008 Jan;81(1 Suppl):26-31.
Harper JC. Tailoring individualized treatment plans for acne. Cutis. 2008 Jan;81(1 Suppl):23-5. Review.
Collier CN, Harper JC, Cafardi JA, Cantrell WC, Wang W, Foster KW, Elewski BE. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol. 2008 Jan;58(1):56-9. Epub 2007 Oct 22. Erratum in: J Am Acad Dermatol. 2008 May;58(5):874. Cafardi, Jennifer A [added].
Sami N, Harper JC. Topical Retinoids. In Wolverton editor: Comprehensive Dermatologic Drug Therapy 2nd edition. 2007.
Harper JC. Antiandrogen therapy for skin and hair disease. Dermatol Clin. 2006 Apr;24(2):137-43, v. Review
Harper J. The use of topical retinoids for inflammatory acne: a review of the pharmacoeconomic considerations. Managed Care Interface 2005;18(3):51-55.
Harper JC. Hormonal therapy for acne using oral contraceptive pills. Seminars in Cutaneous Medicine and Surgery 2005; 24:103-106.
Harper J. An update on the pathogenesis and management of acne vulgaris. J Am Acad Dermatol. 2004;51(1):536-538.
Harper J. Propionibacterium acnes: bacterial resistance to antibiotic medications. Infectious Disease in Children. Sept 2004:10-11
Berson D, Chalker D, Harper J, Leyden J, Shalita A Webster G. Current concepts in the treatment of acne: report from a clinical roundtable. Cutis 2003: 72(1S):5-15.
Harper J. Acne vulgaris. eMedicine 2002
Harper J. Oral contraceptives for acne: a guide to safety and efficacy. Practical Dermatology. 2004; 1(2):29-30.
Harper J. A sensible approach to anti-aging therapy in rosacea. Practical Dermatology. 2004; 1(3):17-18.
Harper J Choosing safe options to manage acne in pregnant women. Practical Dermatology. 2004;1(4):21-23.
Harper J. Light for acne: present realities and possibilities. Practical Dermatology. 2004;1(5):18-19.
Harper J. Environmental factors in acne and rosacea. Practical Dermatology. 2004; 1(6):21-22.
Harper J. Acne and rosacea: no free pass for sun worshippers. Practical Dermatology. 2004;1(7):29-30.
Harper J Diet and Acne: is there a connection. Practical Dermatology. 2004; 1(9):23-24.
Harper J Insight on diagnosing and managing ocular rosacea. Practical Dermatology. 2004; 1(11):29-30.
Harper J A year in review: what 2004 taught us about acne. Practical Dermatology. 2004; 1(12):17-18.
Harper J Dermatology. In: Cooper and Pappas editors: Cecil’s Review of General Internal Medicine 8th edition. Elsevier Inc. 2005: 893-896
Harper J, Thiboutot D. Pathogenesis of acne: recent research advances. In: Yancy editor: Advances in Dermatology 2003; 19:1-10.
Boyce S, Harper J. Paraneoplastic Dermatoses. In:Callen J, Thiers B, editors. Dermatol Clin 2002;20:523-532.
Harper J, Griess T, Hendriks B. DNCB-A Safe Alternative in the Treatment of Warts. Poster March 2001 AAD.
Presentations:
2011 Acne and Rosacea Update
Director
American Academy of Dermatology Annual Meeting
New Orleans, LA
2011 Controversies in Dermatologic Drug Therapy - Presenter
American Academy of Dermatology Annual Meeting
New Orleans, LA
2010 Acne and Rosacea Update
Director
American Academy of Dermatology Annual Meeting
Miami, FL
2010 Controversies in Dermatologic Drug Therapy –Presenter
American Academy of Dermatology Annual Meeting
Miami, FL
2010 The Newest on Drugs, Diet and Diagnosis of Acne
Las Vegas Dermatology
2010 Rosacea News
Las Vegas Dermatology
2010 Topical Treatment in Acne and Rosacea
Alabama Dermatology Society Beach Meeting
Sandestin FL
2009 Hormonal Aspects of Acne Session Director
American Academy of Dermatology Annual Meeting
San Francisco, CA
2009 Should Dermatologist Prescribe Hormonal Contraceptives? - Presenter
American Academy of Dermatology Annual Meeting
San Francisco, CA
2009 Update on Acne in Females
Fall Clinical
Las Vegas, NV
2008 Presenter
American Academy of Dermatology Annual Meeting
San Antonio TX
2008 Acne Controversies
Society of Pediatric Dermatology Annual Meeting
Snowbird UT
2008 Acne Update
Intermountain Dermatology meeting
Sun Valley, ID
2007 Presenter
American Academy of Dermatology Annual Meeting
Washington DC
2007 Community Acquired MRSA
World Congress of Dermatology
Buenos Aires, Argentina
2006 Hormonal Influences in Acne Vulgaris
American Academy of Dermatology Annual Meeting
San Francisco
2005 Acne Symposium Session Director
American Academy of Dermatology Annual Meeting
Chicago, IL
2005 An Alternative Approach to Acne Treatment in Women
Fall Clinical
Las Vegas NV
2004 Hormonal Aspects of Acne Vulgaris
Hawaii Dermatology
2004 Acne in Women
Jazz Festival Meeting –New Orleans
2004 Acne and Acne Foolers
American Academy of Dermatology Annual Meeting
Washington, DC
2004 Acne Vulgaris
Society Dermatology Physician Assistants
Washington, DC
2004 Acne Vulgaris
Dermatology Nurse Association
Orlando, FL
2003 Hormonal Aspects of Acne
Indianapolis Basic Science Review Course
2003 What’s New in Acne Vulgaris
Pacific Dermatology Association
Las Vegas, NV
2003 What’s New in Acne Vulgaris
Fall Clinical Dermatology meeting
Las Vegas, NV
2003 Retinoids in the Management of Acne Vulgaris
Hawaii Dermatology
2003 Retinoids in the Management of Acne Vulgaris
Society of Investigative Dermatology
Miami, FL
2003 Acne and Acne Foolers
AAD San Francisco
Summer AAD Chicago
2003 Update on the Pathogenesis and Management of Acne
American College of Osteopathic Dermatology
Telluride, CA
2002 Update on the Pathogenesis and Management of Acne
Colorado Dermatologic Society
2002 Cost of Acne Therapy
Summer AAD New York
2002 Acne and Acne Foolers
AAD
Summer AAD New York
2002 Hormonal Aspects of Acne
Valley of the Sun Conference
Scottsdale, AZ
2001 Acne and Acne Foolers
Summer AAD Anaheim
2000 Dermatology Primer
Jefferson County Family Practice
2000 Dermatology Primer
American College of Physicians Missouri State Meeting
2000 Dermatology Primer
American College of Physicians Southeast Missouri Chapter
Research:
2010-2011 Evaluation of the cutaneous innate immune and protease responses of
adults to Azelaic gel (Finacea) - Principal Investigator
2010-2011 A Phase IV, Open-label study evaluating the use of Solodyn
(Minicycline HCL extended-release tablets), Ziana and Triaz foaming
cloths as combination acne therapy for potential isotretinoin candidates
- Principal Investigator
2009 An Open Label, 8-week study to evaluate the efficacy and tolerability of MaxClarityII in subjects with acne - Principal Investigator
2004 A 12-week, multicenter, double-blind, randomized, parallel-design
study of 5% dapsone topical gel and vehicle control in patients with acne vulgaris
2003 SBIR Teledermatology Grant Phase I
2003 A phase III Multicenter, randomized, double-blind, active and
vehicle-controlled study of safety and efficacy of velac gel for the
treatment of acne vulgaris.
2002 A randomized double-blind, placebo-controlled, multicenter study
evaluating the efficacy of norgestimate 180-250mcg/EE 25 mcg in
the treatment of moderate acne vulgaris
2002 A 15 week, randomized, double-blind multicenter study comparing the clinical efficacy and safety of azelaic acid 15% gel (SH H 655 BA)
with metronidazole 0.75%gel in patients with papulo-pustular facial
rosacea |
